Moderate intensity static magnetic fields affect mitotic spindles and increase the antitumor efficacy of 5-FU and

Yan Luo1, Xinmiao Ji1, Juanjuan Liu2

  • 1High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, Anhui 230031, PR China.

Insights

Static magnetic fields (SMFs) disrupt cell division by affecting microtubules, leading to abnormal mitotic spindles. These fields enhance the effectiveness of certain chemotherapy drugs like 5-Fluorouracil (5-FU) in cancer treatment.

Area of Science:

  • Cell Biology
  • Oncology
  • Biophysics

Background:

  • Microtubules are crucial for cell division, forming the mitotic spindle.
  • Static magnetic fields (SMFs) are known to affect purified microtubules in vitro.
  • The impact of SMFs on cell division and their therapeutic potential remained unclear.

Purpose of the Study:

  • To investigate the effects of 1 Tesla SMFs on cell division.
  • To determine if SMFs induce defects in mitotic spindles.
  • To explore the potential of SMFs in combination with chemotherapy for cancer treatment.

Main Methods:

  • Utilized synchronization experiments to analyze cell cycle progression.
  • Exposed four human cancer cell lines (HeLa, HCT116, CNE-2Z, MCF7) to SMFs.
  • Assessed the combined effects of SMFs with chemotherapy drugs: 5-Fluorouracil (5-FU), Paclitaxel (Taxol), and Cisplatin.

Main Results:

  • 1T SMFs induced abnormal mitotic spindles and increased the mitotic index.
  • SMFs delayed cell exit from mitosis, causing mitotic arrest, similar to Taxol.
  • SMFs enhanced the antitumor efficacy of 5-FU and 5-FU/Taxol combinations, but not Cisplatin.

Conclusions:

  • SMFs disrupt microtubule dynamics, leading to abnormal mitotic spindles and delayed mitotic exit.
  • SMFs show potential for enhancing the efficacy of specific chemotherapy regimens (5-FU, 5-FU/Taxol) in cancer treatment.
  • The drug-specific interactions highlight the need for tailored combination therapies.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.9K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.3K
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
3.9K
Forces Acting on Chromosomes02:11

Forces Acting on Chromosomes

During mitosis, chromosome movements occur through the interplay of multiple piconewton level forces. In prometaphase, these forces help in chromosome assembly or congression at the equatorial plane, eventually leading to their alignment at the metaphase plate. The forces acting on the chromosomes are space and time-dependent; therefore, they vary with the position of the chromosomes as the cell progresses through mitosis. 
Microtubules and motor proteins exert two types of forces on...
4.1K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
67